ezetimibe has been researched along with Abdominal Aortic Aneurysm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishnan, A; Cassis, LA; Daugherty, A; Howatt, DA; Liu, J; Lu, H; Moorleghen, JJ; Sorci-Thomas, M | 1 |
| Choke, E; Cockerill, GW; Dawson, JA; Loftus, IM; Thompson, MM | 1 |
| Vega de Céniga, M | 1 |
1 trial(s) available for ezetimibe and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
A randomised placebo-controlled double-blind trial to evaluate lipid-lowering pharmacotherapy on proteolysis and inflammation in abdominal aortic aneurysms.
Topics: Aged; Anticholesteremic Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Azetidines; Biopsy; C-Reactive Protein; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Interleukins; Lipids; Male; Matrix Metalloproteinases; Pilot Projects; Simvastatin; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tumor Necrosis Factor-alpha | 2011 |
2 other study(ies) available for ezetimibe and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice.
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Apolipoproteins E; Azetidines; Diet, Western; Disease Models, Animal; Ezetimibe; Female; Hypercholesterolemia; Male; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; Sex Factors | 2015 |
Comments regarding 'A randomised placebo-controlled double-blind trial to evaluate lipid-lowering pharmacotherapy on proteolysis and inflammation in abdominal aortic aneurysms'.
Topics: Anticholesteremic Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Azetidines; Biopsy; Drug Therapy, Combination; Ezetimibe; Humans; Interleukin-6; Matrix Metalloproteinase 9; Randomized Controlled Trials as Topic; Simvastatin | 2011 |